2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Hemangioma
9
Hemangioma, Capillary
7
Melanoma
6
Breast Neoplasms
5
Carcinoma, Hepatocellular
4
Sarcoma
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Hypertension, Portal
3
Hemangiosarcoma
3
Fallopian Tube Neoplasms
3
Urinary Bladder Neoplasms
2
Sarcoma, Kaposi
2
Ovarian Neoplasms
2
Hemangioma, Cavernous, Central Nervous System
2
Colorectal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
von Hippel-Lindau Disease
1
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Ulcer
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Interventions
Everolimus
18
Sirolimus
15
Cannabidiol
6
radiprodil
3
ganaxolone
3
Vigabatrin
3
Activator Appliances
3
Melatonin
2
exemestane
1
dactolisib
1
carbon-11 acetate
1
Urination
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Solutions
1
Simvastatin
1
Sertraline
1
Selective Serotonin Reuptake Inhibitors
1
Propranolol
1
Phlebotomy
1
Itraconazole
1
Injections
1
Genetic Testing
1
Fluid Therapy
1
Doxycycline
1
Curcumin
1
Carbamazepine
1
Calcitriol
1
Aspirin
1
Anticonvulsants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tuberous Sclerosis
×
Propranolol
×
Clear all
NCT02104011
2026-05-19
STBETA
University Hospital, Bordeaux
Phase 2
Completed
2 enrolled